Fig. 2From: Can the cytokine adsorber CytoSorb® help to mitigate cytokine storm and reduce mortality in critically ill patients? A propensity score matching analysisInterleukin-6, lactate and norepinephrine demand on day 0 and day 1, and SAPS II and age on d0 in patients with and without CytoSorb® therapy. green dots, patient survived; black dot, patient died in the hospital; CS, CytoSorb®; SAPS, Simplified Acute Physiology Score; CRP, C-reactive protein; d0, 0–12 h before starting CS therapy (group 1) or the measured IL-6 > 10,000 pg/ml (group 2); d1, 12–24 h after starting CS therapy (group 1) or 12–24 h after d0 IL-6 (group 2); Nor, norepinephrineBack to article page